why choose us

First received: April 04, 2025

Clinical Trial: Comparison of Antiplatelet Effects of Sotagliflozin to FDA-approved Antiplatelet Drugs

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Platelet Function and Reactivity Tests

Study Type: INTERVENTIONAL


Official Title: Comparison of Antiplatelet Effects of Sotagliflozin to FDA-approved Antiplatelet Drugs: an Interventional Study

Brief Summary: This study will identify the potential benefits of regulating platelet activation with sotagliflozin compared to other FDA-approved drugs known to limit platelet activation.

Read more